Hepatocellular carcinoma (HCC) is a prevalent primary liver cancer that is derived from hepatocytes and is characterised by high mortality rate and poor prognosis. While HCC is driven by cumulative changes in the hepatocyte genome, it is increasingly recognised that the liver microenvironment plays a pivotal role in HCC propensity, progression and treatment response. The microenvironmental stimuli that have been recognised as being involved in HCC pathogenesis are diverse and include intrahepatic cell subpopulations, such as immune and stellate cells, pathogens, such as hepatitis viruses, and non-cellular factors, such as abnormal extracellular matrix (ECM) and tissue hypoxia. Recently, a number of novel environmental influences have been s...
The gut microbiota has recently been recognized as a major environmental factor in the pathophysiolo...
The World Health Organization predicts that by 2030 liver cancer will cause 1 million deaths annuall...
Hepatocellular carcinoma (HCC) is a classical inflammation-promoted cancer that occurs in a setting ...
Hepatocellular carcinoma (HCC) is among the most lethal and prevalent cancers in the human populatio...
The gut microbiota is involved in the maintenance of the homeostasis of the human body and its alter...
Gut microbiota plays an essential role in host homeostasis. It is involved in several physiological ...
The prevalence of liver cancer is constantly rising, with increasing incidence and mortality in Euro...
Hepatocellular carcinoma (HCC), one of the leading causes of death worldwide, has a causal nexus wit...
Hepatocellular carcinoma (HCC) accounts for the majority of primary liver cancers. Clearly identifia...
The goal of personalised therapy based on hepatocellular carcinoma (HCC) molecular characteristics i...
Liver cancer is the sixth most common cancer worldwide, and the third most common cause of cancer-re...
Liver cancer is the sixth most common cancer worldwide, and the third most common cause of cancer-re...
Hepatocellular carcinoma (HCC) is a classical inflammation-promoted cancer that occurs in a setting ...
Hepatocellular carcinoma (HCC) mostly develops in patients with chronic liver disease, driven by a v...
Hepatocellular carcinoma (HCC), is one of the most frequent human cancer and is characterized by a ...
The gut microbiota has recently been recognized as a major environmental factor in the pathophysiolo...
The World Health Organization predicts that by 2030 liver cancer will cause 1 million deaths annuall...
Hepatocellular carcinoma (HCC) is a classical inflammation-promoted cancer that occurs in a setting ...
Hepatocellular carcinoma (HCC) is among the most lethal and prevalent cancers in the human populatio...
The gut microbiota is involved in the maintenance of the homeostasis of the human body and its alter...
Gut microbiota plays an essential role in host homeostasis. It is involved in several physiological ...
The prevalence of liver cancer is constantly rising, with increasing incidence and mortality in Euro...
Hepatocellular carcinoma (HCC), one of the leading causes of death worldwide, has a causal nexus wit...
Hepatocellular carcinoma (HCC) accounts for the majority of primary liver cancers. Clearly identifia...
The goal of personalised therapy based on hepatocellular carcinoma (HCC) molecular characteristics i...
Liver cancer is the sixth most common cancer worldwide, and the third most common cause of cancer-re...
Liver cancer is the sixth most common cancer worldwide, and the third most common cause of cancer-re...
Hepatocellular carcinoma (HCC) is a classical inflammation-promoted cancer that occurs in a setting ...
Hepatocellular carcinoma (HCC) mostly develops in patients with chronic liver disease, driven by a v...
Hepatocellular carcinoma (HCC), is one of the most frequent human cancer and is characterized by a ...
The gut microbiota has recently been recognized as a major environmental factor in the pathophysiolo...
The World Health Organization predicts that by 2030 liver cancer will cause 1 million deaths annuall...
Hepatocellular carcinoma (HCC) is a classical inflammation-promoted cancer that occurs in a setting ...